CAR T-Cell Therapy
Showing of 3 results
After months of treatment for 22-year-old Cory Neff’s acute lymphoblastic leukemia (ALL) were unsuccessful, he was transferred to UH Rainbow for specialized care and an innovative immunotherapy treatment.
The therapy is used when the standard treatment for multiple myeloma – a combination of chemotherapy, radiation therapy and/or stem cell transplant – is no longer effective.
With recent advancements in the field of immunotherapy, doctors now can offer some patients new hope in their cancer treatment. Learn more about CAR T-cell therapy.